INTERNATIONAL PATENT: JIANGSU HENGRUI PHARMACEUTICALS CO., LTD., 江苏恒瑞医药股份有限公司 FILES APPLICATION FOR "PHOSPHATE COMPOUND OF SUBSTITUTED PYRAZOLINE AZO DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF"

GENEVA, July 7 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (No.7 Kunlunshan Road, Economic And Technological Development ZoneLianyungang, Jiangsu 222047), 江苏恒瑞医药股份有限公司 (中国江苏省连云港市经济技术开发区昆仑山路7号) filed a patent application (PCT/CN2024/142200) for "PHOSPHATE COMPOUND OF SUBSTITUTED PYRAZOLINE AZO DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF" on Dec 25, 2024. With publication no. WO/2025/140275, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was ...